By Santa Fe Standard |
Apr 29, 2024
The New Mexico Department of Health (NMHealth) has confirmed the presence of xylazine in three fentanyl samples tested through the state’s Adulterant Checking Program.Secretary Patrick Allen of NMHealth emphasized the seriousness of this discovery, stating, “The identification of xylazine puts us on notice that an already dangerous drug supply has gotten that much more deadly.”The Adulterant Checking Program, initiated in November 2023, allows individuals to have substances tested before use as part of the Harm Reduction Program. Joshua Swatek, NMHealth Hepatitis and...